Trunk control exercise for Parkinson's (NCT07610031)

Improve trunk posture and balance

Trial ID
NCT07610031
Official Title
Effects of Trunk Control Exercises and Mirror Therapy on Balance and Posture in Patients With Parkinson's Disease
Goal
Improve trunk posture and balance
Phase
NA
Status
RECRUITING
Sponsor
University of Lahore
Study Type
INTERVENTIONAL
Enrollment
36 participants
Conditions
Parkinson s Disease
Interventions
Trunk control exercise, Mirror therapy

Summary For Families

Aiming to reduce balance problems and poor trunk posture that can cause falls and a stooped gait in Parkinson's, this trial tests whether focused core training plus visual feedback can improve upright stability. It combines trunk control exercises to strengthen and coordinate the core muscles that support posture, with mirror therapy that provides visual feedback to retrain movement symmetry and motor patterns; these are rehab approaches meant to complement, not replace, a person’s usual Parkinson’s medications. Looking for people aged 50 to 70 with mild to moderate Parkinson’s (Hoehn and Yahr stages 1,3), on a fixed medication dose, with normal cognition (Mini‑Mental score 24,30), able to rise from a chair without help, and without major dyskinesias, recent seizures or trauma, or unstable cardiovascular disease.

Locations

  • Nimra Nadeem, Lahore, Punjab Province, Pakistan

Frequently Asked Questions

What is this trial testing?
This trial is studying Trunk control exercise. Aiming to reduce balance problems and poor trunk posture that can cause falls and a stooped gait in Parkinson's, this trial tests whether focused core training plus visual feedback can improve upright stability. It combines trunk control exercises to strengthen and coordinate the core muscles that support posture, with mirror therapy that provides visual feedback to retrain movement symmetry and motor patterns; these are rehab approaches meant to complement, not replace, a person’s usual Parkinson’s medications. Looking for people aged 50 to 70 with mild to moderate Parkinson’s (Hoehn and Yahr stages 1,3), on a fixed medication dose, with normal cognition (Mini‑Mental score 24,30), able to rise from a chair without help, and without major dyskinesias, recent seizures or trauma, or unstable cardiovascular disease.
Who can participate?
Participants must be between 50 Years and 70 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
How long does the trial last?
This trial is estimated to last approximately 1 year and 6 months.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
Will I get a placebo in this trial?
There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
How many visits does this trial involve?
Data will be collected at baseline and then at the end of the sixth week.
What procedures are involved in this trial?
Based on the protocol, this trial involves: Thinking & memory tests (non-invasive). Confirm the full schedule with the study coordinator.

Related Reading

View on ClinicalTrials.gov